The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of a reduced dose of enzalutamide on fatigue and cognition.
 
Joanneke Overbeek
No Relationships to Disclose
 
Emmy Boerrigter
No Relationships to Disclose
 
Guillemette Emma Benoist
No Relationships to Disclose
 
Diederik Meindert Somford
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Janssen; MSD
Speakers' Bureau - Bayer
 
Paul Hamberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD; Pfizer
 
Jolien Tol
Consulting or Advisory Role - Amgen
 
Brian Scholtes
Consulting or Advisory Role - AstraZeneca; Janssen; Novartis; Pierre Fabre
 
Annelieke E.C.A.B. Willemsen
Consulting or Advisory Role - AstraZeneca
 
Laurien M Buffart
No Relationships to Disclose
 
Roy P.C. Kessels
Patents, Royalties, Other Intellectual Property - BSL (I); Hogrefe; LannooCampus; Taylor Francis
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology (Inst)
Research Funding - Astellas Pharma (Inst); AstraZeneca/Merck (Inst); Janssen-Cilag (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Roche
 
Inge M. van Oort
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Research Funding - Astellas Pharma (Inst); Bayer (Inst)
 
Nielka P. Van Erp
Research Funding - Astellas Pharma (Inst); Ipsen (Inst)